Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure

R Licordari, M Correale, S Bonanno, M Beltrami… - Biomolecules, 2024 - mdpi.com
Heart failure (HF) represents a significant global health challenge, characterized by high
morbidity and mortality rates, and imposes considerable burdens on healthcare systems and …

Established and emerging roles of biomarkers in heart failure

NE Ibrahim, JL Januzzi Jr - Circulation research, 2018 - Am Heart Assoc
Heart failure (HF) is a complex syndrome with an enormous societal burden in terms of cost,
morbidity, and mortality. Natriuretic peptide testing is now widely used to support diagnosis …

Do Heart Failure Biomarkers Influence Heart Failure Treatment Response?

T Yuen, P Gouda, R Margaryan, J Ezekowitz - Current Heart Failure …, 2023 - Springer
Abstract Purpose of Review Heart failure (HF) is one of the leading causes of cardiac
morbidity and mortality around the world. Our evolving understanding of the cellular and …

Clinical adoption of prognostic biomarkers: the case for heart failure

AP Kalogeropoulos, VV Georgiopoulou… - Progress in cardiovascular …, 2012 - Elsevier
The recent explosion of scientific knowledge and technological progress has led to the
discovery of a large array of circulating molecules commonly referred to as biomarkers …

Beyond natriuretic peptides for diagnosis and management of heart failure

NE Ibrahim, JL Januzzi Jr - Clinical chemistry, 2017 - academic.oup.com
BACKGROUND Heart failure (HF) is a complex syndrome with an enormous societal burden
in terms of cost and morbidity and mortality. Natriuretic peptide (NP) testing is now widely …

[HTML][HTML] Novel Biomarkers in Early Detection of Heart Failure: A Narrative Review

M Kayani, N Fatima, PC Yarra, NE Almansouri… - Cureus, 2024 - ncbi.nlm.nih.gov
Heart failure (HF) represents a significant global health challenge, characterized by a variety
of symptoms resulting from cardiac dysfunction. This dysfunction often leads to systemic and …

Old and newer biomarkers in heart failure: from pathophysiology to clinical significance

N Sherwi, P Pellicori, AC Joseph… - Journal of Cardiovascular …, 2013 - journals.lww.com
Heart failure is a complex disease in which a careful clinical examination and the
measurement of cardiac function may not always be sufficient for making a correct …

The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure

SR Motiwala, JL Januzzi Jr - Clinical Pharmacology & …, 2013 - Wiley Online Library
The current standard treatment of chronic heart failure (HF) is based on clinical judgment,
with the goal of achieving the maximally tolerated therapeutic program. The complexity of …

[HTML][HTML] Surfing the Biomarker Tsunami at JACC: Heart Failure

JL Januzzi, GM Felker - JACC: Heart Failure, 2013 - jacc.org
Although heart failure (HF) remains a fundamentally clinical diagnosis, substantial advances
in the understanding of the underlying biology and pathophysiology of this syndrome has …

Biomarkers in heart failure: the past, current and future

M Sarhene, Y Wang, J Wei, Y Huang, M Li, L Li… - Heart failure …, 2019 - Springer
Despite the enhanced knowledge of the pathophysiology of heart failure (HF), it still remains
a serious syndrome with substantial morbidity, mortality, and frequent hospitalizations …